ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204
Published July 22, 2026 · Recall initiated: June 12, 2026
Summary
FDA records medical device Class II recall Z-2746-2026, published July 22, 2026 and initiated June 12, 2026. Recalling firm: Tosoh Bioscience Inc; Status: Ongoing; Reported quantity: 310 units; Lot: UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Tosoh Bioscience Inc
- Distributor
- Global Distribution. US Nationwide.
- Lot
- UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDALevothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, RxJuly 29, 2026
- FDAPhotera 600 3-D, phototherapy device; Ultraviolet Lamp For Dermatologic DisordersJuly 22, 2026
- FDATosoh Bioscience AIA-PACK BHCG Calibration Verification Test Set-In Vitro Diagnostic for BHCG-pregnancy PartSeptember 23, 2020
- FDAST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for theJanuary 2, 2019
- FDAAIA-PACK Folate (FOL) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of folateJanuary 2, 2019
- FDAST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurementJanuary 2, 2019
Questions about this recall
Was ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204 recalled?
Yes. FDA published recall Z-2746-2026 on July 22, 2026. Reported hazard: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.
What should I do if I have this product?
Voluntary: Firm initiated · Letter